Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-20-081704
Filing Date
2020-07-07
Accepted
2020-07-07 16:05:28
Documents
1
Period of Report
2020-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2024232-1_8ka.htm 8-K/A 18422
  Complete submission text file 0001104659-20-081704.txt   19575
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38944 | Film No.: 201016182
SIC: 2834 Pharmaceutical Preparations